| Synonyms: | |
| Status: | Approved (2014) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | OU2YM37K86 |
| InChI Key | UAUIUKWPKRJZJV-QPLHLKROSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C40H43N7O7S |
| Molecular Weight | 765.89 |
| AlogP | 3.64 |
| Hydrogen Bond Acceptor | 10.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 189.65 |
| Molecular species | ACID |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 55.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Hepatitis C virus serine protease, NS3/NS4A inhibitor | FDA |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
Serine protease S29 regulatory subfamily
|
- | - | - | - | 97 | |
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S29 family
|
- | - | - | - | 97 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hepatitis B, Chronic | 2 | D019694 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1216941-48-8 |
| ChEMBL | CHEMBL3391662 |
| DrugBank | DB09297 |
| DrugCentral | 4913 |
| FDA SRS | OU2YM37K86 |
| Guide to Pharmacology | 11273 |
| PharmGKB | PA166163410 |
| PubChem | 45110509 |
| SureChEMBL | SCHEMBL3069964 |
| ZINC | ZINC000197964623 |